To The Moon

As the financial world grapples with uncertainty and the ever-evolving global landscape, Palantir Technologies (NYSE: PLTR) stands as a symbol of resilience and long-term potential. In this article, we will delve into the compelling reasons behind my decision to increase my investment in Palantir and why I believe it’s an outstanding long-term prospect. The recent surge in government contracts, including a substantial win with the U.S. Army and the National Health Service (NHS), has only strengthened my conviction in Palantir’s future. $Palantir Technologies Inc.(PLTR)$ 

1. A Legacy of Securing Nations:

• Palantir’s Historical Involvement with the US Government on Counterterrorism: Palantir has a storied history of collaborating with the U.S. government in the fight against terrorism. The company’s data analytics platforms have been instrumental in gathering and analyzing crucial intelligence to enhance national security. This legacy of trust and effectiveness has solidified its reputation as a key partner in safeguarding the nation.

• The Israel War and Palantir’s Potential Role: The outbreak of the Israel War on October 7, 2023, sparked concerns and uncertainties in the global landscape. It’s intriguing to note that Palantir’s share price witnessed a notable uptick during this period. This surge could be attributed to market speculation that the Israeli government might engage Palantir’s services to support its efforts during the conflict. If such a partnership materializes, it could significantly bolster Palantir’s revenue and market standing.

2. Recent Government Contracts: A Game-Changer for Palantir:

• Palantir’s recent wins in the government sector have been nothing short of game-changing. First, the U.S. Army awarded Palantir a substantial contract worth over US$250 million. This contract, extending through September 25, 2026, primarily focuses on research related to artificial intelligence (AI) and machine learning. The military’s choice of Palantir speaks volumes about the company’s capabilities in data-driven research and analytics.

• The NHS Contract and Its Significance: Another remarkable triumph for Palantir is the potential contract with the NHS to overhaul the UK’s healthcare data infrastructure. This contract, valued at more than US$500 million, could extend up to five years and possibly an additional two years. Palantir’s expertise in data analytics will be pivotal in analyzing medical data, detecting patterns, and revamping the entire healthcare system. This deal, subject to final approvals, is poised to provide a significant boost to Palantir’s financial performance and reputation.

3. A Bullish Outlook and Target Price:

• My confidence in Palantir’s long-term prospects is underpinned by these recent developments. The company’s ability to secure substantial government contracts, coupled with its proven track record in aiding national security efforts, reinforces my bullish outlook. As of now, my target price for Palantir by the end of the year exceeds $18. I believe that the company’s expanding portfolio of government contracts and its commitment to data-driven innovation will be the driving forces behind this growth.

Conclusion:

Palantir’s resilience and long-term growth potential are evident in its historical involvement with the U.S. government, its potential role in global crises like the Israel War, and its recent high-value contracts. These developments are not only significant milestones for Palantir but also indicative of its future trajectory. I remain committed to my investment in Palantir and believe that its share price will continue to climb as it secures more contracts and delivers on its promise of data-driven excellence.

Please like and share your view on Palantir!

I would greatly appreciate it if you could consider featuring this article, as it could provide valuable insights into my investment and trading strategies for the benefit of fellow Tiger Investors/Traders. @CaptainTiger @Trend_Radar @MillionaireTiger @Tiger_SG @TigerClub @TigerWire @Daily_Discussion